Advertisement
U.S. Markets close in 5 hrs 12 mins

NovoCure Limited (NVCR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
17.59+0.50 (+2.93%)
As of 10:48AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close17.09
Open17.20
Bid17.48 x 100
Ask17.75 x 100
Day's Range17.09 - 17.71
52 Week Range11.29 - 24.74
Volume95,099
Avg. Volume1,037,006
Market Cap1.903B
Beta (5Y Monthly)0.70
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Medical Device Network

    Novocure secures FDA approval for add-ons to brain cancer treatment wearable

    Novocure has refined the transducer arrays that attach to Optune Gio, its wearable for glioblastoma treatment.

  • TipRanks

    NovoCure’s Strong Q3 and Leadership Changes in 2024

    NovoCure ( (NVCR) ) just unveiled an announcement. Novocure reported a robust third quarter in 2024, with net revenues surging by 22% to $155 million, driven by successful market expansions and improved approval rates in the U.S. The company also celebrated FDA approval of Optune Lua for metastatic non-small cell lung cancer, marking a significant milestone. Additionally, management transitions are underway with Christoph Brackmann taking over as CFO from January 2025, as Novocure aims to sustai